IMU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ImmunoGen Inc

Watchlist Manager

Watchlist

Price: 28.96 EUR -0.07%

Market Cap: €1.4B

I	ImmunoGen Inc XBER:IMU	US
G	Gold Fields Ltd XBER:EDGA	ZA
A	Abbott Laboratories SWB:ABL	US
M	Modine Manufacturing Co SWB:MMF	US
K	Keel Infrastructure Corp NASDAQ:KEEL	US
A	Anhui Conch Cement Co Ltd XBER:AQE	CN
C	Canadian Tire Corporation Ltd SWB:YAAA	CA
L	Liberty Global PLC XBER:1LGC	UK
T	Texas Instruments Inc XMUN:TII	US
G	Gold Road Resources Ltd XBER:E6Q	AU
	Lumine Group Inc F:Z76	CA

Profitability Summary

ImmunoGen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

88%

Gross Margin is Increasing

75% > 99%

Negative Operating Margin

-28%

Negative 3Y Average Operating Margin

-108%

Operating Margin is Increasing

-199% > -28%

Negative Net Margin

-26%

Negative 3Y Average Net Margin

-107%

Net Margin is Increasing

-199% > -26%

Negative Free Cash Flow Margin

-69%

Negative 3Y Average Free Cash Flow Margin

-143%

Free Cash Flow Margin is Increasing

-218% > -69%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-298%

ROIC is Increasing

-582% > -74%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.